title: Injectable extended-release naltrexone for opioid dependence.
authors.forename: Douglas C
authors.initials: DC
authors.lastname: Throckmorton
authors.forename: Robert
authors.initials: R
authors.lastname: Temple
authors.forename: Bob A
authors.initials: BA
authors.lastname: Rappaport
authors.forename: Rigoberto
authors.initials: R
authors.lastname: Roca
authors.forename: Celia J
authors.initials: CJ
authors.lastname: Winchell
mesh_terms: D003692:Delayed-Action Preparations; D017277:Drug Approval; D006801:Humans; D007267:Injections; D009271:Naltrexone / Q000008:administration & dosage*; D009292:Narcotic Antagonists / Q000008:administration & dosage*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D003692:Delayed-Action Preparations; D009292:Narcotic Antagonists; D009271:Naltrexone